Perception of Hormonal Replacement Therapy Among Patients Aged 11 to 17 Years

Current Knowledge and Perceptions of Hormone Replacement Therapy Among Patients Aged 11 to 18 Years, and Their Parents, Treated for Hypogonadism at the Strasbourg University Hospital

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07315932

Acronym

THS

Enrollment

Registered

2026-01-05

Start date

2025-03-23

Completion date

2026-02-28

Last updated

2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female Hypogonadism

Keywords

Female Hypogonadism, Central hypogonadism, Peripheral hypogonadism, hormone replacement therapy

Brief summary

To establish a current knowledge and perception of patients and their parents regarding HRT in order to assess the needs that can promote understanding and adherence to treatment by implementing therapeutic education workshops

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

11 Years to 18 Years

Inclusion criteria

* Female patients aged 11 to 18 years * Treated at the University Hospital of Strasbourg for central or peripheral hypogonadism with the initiation of hormone replacement therapy

Exclusion criteria

\- Inability to provide the subject with clear information (difficulties understanding the subject, language barrier, illiteracy, etc.)

Design outcomes

Primary

Measure	Time frame	Description
Assessment of patients' knowledge about the composition of hormonal treatment for female hypogonadism	Up to 7 months	The aim is to assess the knowledge of patients aged 11 to 18 about the composition of hormone treatment for female hypogonadism using a questionnaire.
Assessment of patients' knowledge regarding the effects of hormonal treatment for female hypogonadism	Up to 7 months	The aim is to assess the knowledge of patients aged 11 to 18 years about the effects of hormone treatment for female hypogonadism using a questionnaire.

Countries

France

Contacts

Primary ContactMathilda KRETZ, MD

mathilda.kretz@chru-strasbourg.fr33 3 88 11 67 68

Outcome results